Your browser doesn't support javascript.
loading
Risk factors for postoperative complications after adrenalectomy for phaeochromocytoma: multicentre cohort study.
Parente, Alessandro; Kamarajah, Sivesh K; Thompson, Joseph P; Crook, Charlotte; Aspinall, Sebastian; Melvin, Ross; Stechman, Michael J; Perry, Helen; Balasubramanian, Sabapathy P; Pannu, Arslan; Palazzo, Fausto F; Van Den Heede, Klaas; Eatock, Fiona; Anderson, Hannah; Doran, Helen; Wang, Kelvin; Hubbard, Johnathan; Aldrees, Abdulaziz; Shore, Susannah L; Fung, Clare; Waghorn, Alison; Ayuk, John; Bennett, Davinia; Sutcliffe, Robert P.
Afiliação
  • Parente A; HPB Surgery Unit, Queen Elizabeth Hospital, Birmingham, UK.
  • Kamarajah SK; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Thompson JP; HPB Surgery Unit, Queen Elizabeth Hospital, Birmingham, UK.
  • Crook C; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Aspinall S; HPB Surgery Unit, Queen Elizabeth Hospital, Birmingham, UK.
  • Melvin R; HPB Surgery Unit, Queen Elizabeth Hospital, Birmingham, UK.
  • Stechman MJ; Department of General Surgery, Aberdeen Royal Infirmary, Aberdeen, UK.
  • Perry H; Department of General Surgery, Aberdeen Royal Infirmary, Aberdeen, UK.
  • Balasubramanian SP; Department of Endocrine Surgery, University Hospital Wales, Cardiff, UK.
  • Pannu A; Department of Endocrine Surgery, University Hospital Wales, Cardiff, UK.
  • Palazzo FF; Department of General Surgery, Sheffield Teaching Hospitals Foundation Trust, Sheffield, UK.
  • Van Den Heede K; Department of General Surgery, Sheffield Teaching Hospitals Foundation Trust, Sheffield, UK.
  • Eatock F; Department of Endocrine Surgery, Hammersmith Hospital, London, UK.
  • Anderson H; Department of Endocrine Surgery, Hammersmith Hospital, London, UK.
  • Doran H; Department of Endocrine Surgery, Royal Victoria Hospital, Belfast, UK.
  • Wang K; Department of Endocrine Surgery, Royal Victoria Hospital, Belfast, UK.
  • Hubbard J; Department of Endocrine Surgery, Salford Royal Hospital, Salford, UK.
  • Aldrees A; Department of Endocrine Surgery, Salford Royal Hospital, Salford, UK.
  • Shore SL; Department of Endocrine Surgery, St Thomas' Hospital, London, UK.
  • Fung C; Department of Endocrine Surgery, St Thomas' Hospital, London, UK.
  • Waghorn A; Department of Endocrine and Breast Surgery, Royal Liverpool and Broadgreen University Hospitals Trust, Liverpool, UK.
  • Ayuk J; Department of Endocrine and Breast Surgery, Royal Liverpool and Broadgreen University Hospitals Trust, Liverpool, UK.
  • Bennett D; Department of Endocrine and Breast Surgery, Royal Liverpool and Broadgreen University Hospitals Trust, Liverpool, UK.
  • Sutcliffe RP; Department of Endocrinology, Queen Elizabeth Hospital, Birmingham, UK.
BJS Open ; 7(5)2023 09 05.
Article em En | MEDLINE | ID: mdl-37757753
ABSTRACT

BACKGROUND:

To determine the incidence and risk factors for postoperative complications and prolonged hospital stay after adrenalectomy for phaeochromocytoma.

METHODS:

Demographics, perioperative outcomes and complications were evaluated for consecutive patients who underwent adrenalectomy for phaeochromocytoma from 2012 to 2020 in nine high-volume UK centres. Odds ratios were calculated using multivariable models. The primary outcome was postoperative complications according to the Clavien---Dindo classification and secondary outcome was duration of hospital stay.

RESULTS:

Data were available for 406 patients (female n = 221, 54.4 per cent). Two patients (0.5 per cent) had perioperative death, whilst 148 complications were recorded in 109 (26.8 per cent) patients. On adjusted analysis, the age-adjusted Charlson Co-morbidity Index ≥3 (OR 8.09, 95 per cent c.i. 2.31 to 29.63, P = 0.001), laparoscopic converted to open (OR 10.34, 95 per cent c.i. 3.24 to 36.23, P <0.001), and open surgery (OR 11.69, 95 per cent c.i. 4.52 to 32.55, P <0.001) were independently associated with postoperative complications. Overall, 97 of 430 (22.5 per cent) had a duration of stay ≥5 days and this was associated with an age-adjusted Charlson Co-morbidity Index ≥3 (OR 4.31, 95 per cent c.i. 1.08 to 18.26, P = 0.042), tumour size (OR 1.15, 95 per cent c.i. 1.05 to 1.28, P = 0.006), laparoscopic converted to open (OR 32.11, 95 per cent c.i. 9.2 to 137.77, P <0.001), and open surgery (OR 28.01, 95 per cent c.i. 10.52 to 83.97, P <0.001).

CONCLUSION:

Adrenalectomy for phaeochromocytoma is associated with a very low mortality rate, whilst postoperative complications are common. Several risk factors, including co-morbidities and operative approach, are independently associated with postoperative complications and/or prolonged hospitalization, and should be considered when counselling patients.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Feocromocitoma / Neoplasias das Glândulas Suprarrenais Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Feocromocitoma / Neoplasias das Glândulas Suprarrenais Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article